Brachytherapy combination improves PSA-free Survival for patients with higher-risk localized prostate cancer, trial finds

Brachytherapuy seeds placement
Brachytherapy – where seeds are placed.

April 29, 2015. Many patients with higher-risk localized prostate cancer are treated with external beam radiation or with brachytherapy (seed implants). A clinical trial conducted by Dr James Miller (right) of Vancouver, Canada has found that patients receiving permanent implant brachytherapy “seeds” plus a boost of radiation have a better chance of long-term survival than those treated with higher dose-escalated external beam radiotherapy but without the implants.

Men receiving the radioactive “seeds” were more likely to be cancer-free five to nine years later. Continue reading “Brachytherapy combination improves PSA-free Survival for patients with higher-risk localized prostate cancer, trial finds”

Obesity Increases Prostate Cancer Risk for African-American Men

April 23, 2015. African American men have the highest rates of prostate cancer incidence and mortality in the United States. For the past twenty years cancer researchers have worried about this and researched various causal factors. Now a large study suggests obesity may play an important role in what specialists in disparities in prostate cancer risk are calling the “African-American race effect.”

Continue reading “Obesity Increases Prostate Cancer Risk for African-American Men”